Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Equitable Holdings Inc. Common Stock (EQH) vs Edgewise Therapeutics Inc. Common Stock (EWTX) Price & Performance

Equitable Holdings Inc. Common StockTrade
Edgewise Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Equitable Holdings Inc. Common Stock vs Edgewise Therapeutics Inc. Common Stock — how do they compare? Equitable Holdings Inc. Common Stock trades at $52.77 (market cap $14.42B), while Edgewise Therapeutics Inc. Common Stock trades at $37.11 (market cap $4.02B). The key difference: Equitable Holdings Inc. Common Stock is far larger — about 3.6× Edgewise Therapeutics Inc. Common Stock's market cap, and Equitable Holdings Inc. Common Stock pays a 2.16% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Equitable Holdings Inc. Common Stock for 0 Days and Edgewise Therapeutics Inc. Common Stock for 0 Days on average.

EQHEWTX
Market Cap
$14.42B$4.02B
Volume
2,107,2981,446,128
Sector
FinancialsHealth
52-Week High
$54.50$48.35
52-Week Low
$35.34$14.89
Typical Hold Time
0 Days0 Days
Enterprise Value
$5.48B$3.56B
Dividend Yield
2.16%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Equitable Holdings Inc. Common Stock

Equitable Holdings (EQH) trades at $53.12, down 0.75% on the day, with strong analyst support (95% buy ratings) and a $64.71 consensus price target suggesting 22% upside. Recent quarterly earnings have consistently beaten expectations, though the company reported a net loss of $1.38B for 2025. The planned merger with Corebridge and expansion into fee-based businesses are key growth drivers, while high debt-to-asset ratio of 2.07 presents financial risk.

EQH shows mixed fundamentals with positive earnings momentum but negative profitability metrics. The stock offers significant upside potential based on analyst targets, supported by strategic initiatives and dividend appeal. Key risks include execution of the Corebridge merger, persistent net losses, and high leverage. Investors should weigh strong analyst conviction against fundamental weaknesses.

Edgewise Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EQH
100% Buy0% Sell
Avg holding period · 0 Days
EWTX
100% Buy0% Sell
Avg holding period · 0 Days

About Equitable Holdings Inc. Common Stock

Equitable Holdings, Inc. is a financial services holding company operating through Equitable, AllianceBernstein, and Equitable Advisors. It provides retirement and protection products, asset and wealth management services, and financial planning through a network of registered financial professionals.

Read more on EQH →

About Edgewise Therapeutics Inc. Common Stock

Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.

Read more on EWTX →